Skip to content
Catalyst

PapersPMID:34839399

Cardiovascular disease risk reduction with wolfberry consumption: a systematic review and meta-analysis of randomized controlled trials.

European journal of nutrition2022The record ↗

findings
2
compound
1
endpoints
2
  1. Finding, very limited evidencelowersTriglycerides
  2. Finding, very limited evidenceraisesHDL cholesterol
Study, every finding
meta-analysis
Population, every finding
Participants of 10 randomised controlled trials of wolfberry consumption, whole wolfberry and wolfberry extract trials pooled
  • “Compared to the control, groups which consumed wolfberry showed a reduction in blood triglycerides [WMDpooled (95% confidence interval): - 0.14 (- 0.19, - 0.09) mmol/L] and increased blood high-density lipoprotein cholesterol [WMDpooled: 0.06 (0.02, 0.09) mmol/L].”

Study record

Design
meta-analysis
Species
human
Population
not reported
Participants
not reported
Comparator
not stated in the paper
Duration
not reported
Endpoints measured
9